Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -4 of 4 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Evaluating the Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 Treatment

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Supportive care, Treatment				Active				18 to 75				NIMH				R01 MH071580 DATR A3-NSS, NCT00352885


2.		Evaluating the Effectiveness of Escitalopram to Prevent Depression in Head and Neck Cancer Patients Receiving Treatment

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Supportive care				Active				19 and over				NIMH				R01 MH079420 DAHBR 96-BHC, NCT00536172

Last Modified: 12/8/2006 First Published: 10/6/2006


3.		Randomized Study of Escitalopram Oxalate in Treating a Major Depressive Disorder in Patients With Stage IIIB or IV Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Supportive care				Active				35 to 85				NCI				MGH-2006-P-000299 NCT00387348

Last Modified: 11/19/2008 First Published: 4/23/2008


4.		Study of the Pharmacokinetics of Tamoxifen Citrate in Women With or At High Risk For Developing Breast Cancer Who Are Receiving Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor Therapy Comprising Venlafaxine, Citalopram Hydrobromide, Escitalopram Oxalate, Gabapentin, or Sertraline Hydrochloride for the Treatment of Hot Flashes, Depression, or Any Other Medically Indicated Condition

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Biomarker/Laboratory analysis, Treatment				Active				18 and over				NCI				MAYO-MC0738 MC0738, NCT00667121

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute